Biological characterization of stage T-1 transitional-cell carcinoma of the bladder

Citation
V. Buchumensky et al., Biological characterization of stage T-1 transitional-cell carcinoma of the bladder, MOL UROL, 2(4), 1998, pp. 301-304
Citations number
8
Categorie Soggetti
Urology & Nephrology
Journal title
MOLECULAR UROLOGY
ISSN journal
10915362 → ACNP
Volume
2
Issue
4
Year of publication
1998
Pages
301 - 304
Database
ISI
SICI code
1091-5362(199824)2:4<301:BCOSTT>2.0.ZU;2-5
Abstract
To assess the biological characteristics of transitional-cell carcinoma of the bladder (TCC), Stage T-1, which may be helpful in evaluating the approp riate treatment at this stage of disease, urine from 78 newly presenting pa tients who were candidates for transurethral resection (TUR) of tumors was analyzed cytologically and the number of tumors in each patient counted. In addition, the following biological characteristics of the resected tumors were examined: grade, cellular atypia, nuclear area, mitotic index, diploid fraction, S-phase fraction (percent), DNA index, and aneuploid fraction (n umber). The biological features were compared with the clinical status of p atients. In 46 patients, the tumors were Stage pT(a) Grade 1-3; 19 were Sta ge pT(1) Grade 2-3, and 13 were Stage pT(2,3). The T-1 category of TCC appe ared far more aggressive than T-a TCC after examining the various biologica l features, and when considering mitotic index and urine cytology, it was f ound to be more aggressive even in comparison with the T-2,T-3 category. Th e maximum mitotic index in the T-2,T-3 category was 19.2; in the T-1 catego ry, 53% of the tumors had a higher mitotic index. The minimal mitotic index found in the T-1 category in our study was 4.07. There was no correlation between the number of tumors and the stage of the disease. Among the 15 pat ients at stage T-1 who were available for follow-up, in 8 patients, a mitot ic index above 19.2 was found, and they were considered at high risk for pr ogression. In this subgroup of patients, the time to first recurrence was s ignificantly shorter than in the subgroup of T1 patients with a mitotic ind ex below 19.2 (6.13 +/- 1.3 v 11.5 +/- 1.93 months). In the high-risk subgr oup, two patients died of metastatic disease, whereas only one patient from the low-risk subgroup died, and that was of causes not related to carcinom a of the bladder. Biologically, TCC at Stage T-1 is far more aggressive tha n T-a TCC and cannot be classified as a superficial tumor. Tumors at Stage pT(1) with a mitotic index above 19.2 constitute a very malignant subgroup of T-1 tumors and may appropriately be treated by radical cystectomy after the first recurrence.